JRoon, If the generic companies win the Sherman Act suit, what happens next? If the government determines that Amarin is guilty of monopolistic business practices, their exclusive contracts will be terminated. This would prevent Amarin from ever being able to compete on pricing. We know that undercutting generic wholesale pricing has been the strategy to maintain US market share. At that point the US market would be lost. What options would Amarin have then? The ability of the government to enforce the Sherman Act doesn't extend beyond the US boarder. Amarin can't afford to have those agreements terminated. The only choice would be for Amarin, to withdraw from the US market. Generic companies don't win by winning. All of the Sherman Act suits are being consolidated into the DRL v Amarin suit. With each additional plaintiff reducing the monetary reward for the companies involved.i don't see how a "money grab" would be a motivation. When the court assess monetary damages, it will be based on the generic indication.
Sleven,
Market Data 
Markets 
AI
